1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

13Dec/11

Agent discovery could protect against atherosclerosis – Barchester Healthcare

December 13, 2011Other Transplantationadmin

Agent discovery could protect against atherosclerosisBarchester HealthcareBone marrow transplantation experiments also indicated that A2bAR bone marrow cell signals alone were not sufficient to elicit this effect. A2bAR is an anti-inflammatory and has …

13Dec/11

BiovaxID(R) Lymphoma Vaccine-Induced T-Cell Immune Responses Complement … – MarketWatch (press release)

December 13, 2011Monoclonal Anti-CD20 Antibodiesadmin

BiovaxID(R) Lymphoma Vaccine-Induced T-Cell Immune Responses Complement …MarketWatch (press release)The results (detailed in Abstract #2707), reported by a Senior Investigator from the NCI, demonstrated that vaccination with BiovaxID active immunothe…

13Dec/11

HIV drug reduces graft-versus-host disease in stem cell transplant patients … – EurekAlert (press release)

December 13, 2011Other Transplantationadmin

HIV drug reduces graft-versus-host disease in stem cell transplant patients …EurekAlert (press release)(SAN DIEGO) — An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease …

13Dec/11

Abbott Labs Spinoff Looks Like the Right Move – Investorplace.com

December 13, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Abbott Labs Spinoff Looks Like the Right MoveInvestorplace.comAlso in development is daclizumab, which appears to be both safe and effective in treating the most common form of multiple sclerosis. Phase III testing is also underway for bardoxolone, whi…

13Dec/11

15 Per Cent Of Malaysians At Risk Of Chronic Kidney Disease – Health Director … – Bernama

December 13, 2011Organ Failureadmin

15 Per Cent Of Malaysians At Risk Of Chronic Kidney Disease – Health Director …BernamaKUALA LUMPUR, Dec 13 (Bernama) — Fifteen per cent or 4.2 million of the Malaysian population are at risk of chronic kidney disease (CKD), Director-General of Healt…

13Dec/11

Onyx Pharmaceuticals Experience Tumbling of Shares – French Tribune

December 13, 2011Other Transplantationadmin

French TribuneOnyx Pharmaceuticals Experience Tumbling of SharesFrench TribuneAn expert from the Department of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia Section at the Washington University School of Medicine, Ravi Vij, wh…

13Dec/11

Managing glucose levels may not lower heart failure risk for diabetics – Diabetes.co.uk

December 13, 2011Organ Failureadmin

Managing glucose levels may not lower heart failure risk for diabeticsDiabetes.co.ukA study carried out by scientists in Glasgow has found that for people who have type 2 diabetes, close control of their glucose levels does not necessarily offer a redu…

13Dec/11

Iron Homeostasis Signatures Predict Immunosuppression Withdrawal for Liver … – Genetic Engineering News

December 13, 2011Transplantationadmin

Iron Homeostasis Signatures Predict Immunosuppression Withdrawal for Liver …Genetic Engineering NewsTheir paper is titled “Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver…

13Dec/11

First operations on kidney transplantation held in Azerbaijan – Azerbaijan Business Center

December 13, 2011Transplantationadmin

Azerbaijan Business CenterFirst operations on kidney transplantation held in AzerbaijanAzerbaijan Business CenterRepublican Urology Clinics named after M. Javadzadeh has commenced holding operations on kidney transplantation. Health Ministry reports th…

13Dec/11

Roche's blood cancer antibody outperforms MabThera – PMLiVE

December 13, 2011Monoclonal Anti-CD20 Antibodiesadmin

Roche's blood cancer antibody outperforms MabTheraPMLiVERoche says it will now press on with phase III testing of GA101 as an alternative to MabThera (rituximab), which was originated by Biogen Idec and is sold by Roche outside the USA and Japan. T…

Posts navigation

  • « Previous
  • 1
  • …
  • 17,938
  • 17,939
  • 17,940
  • 17,941
  • 17,942
  • …
  • 18,211
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos